| Style | Citing Format |
|---|---|
| MLA | Balighi K, et al.. "Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19." Dermatologic Therapy, vol. 35, no. 4, 2022, pp. -. |
| APA | Balighi K, Ansari MS, Hashemi Urimi B, Ghanadan A, Tootoonchi N (2022). Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19. Dermatologic Therapy, 35(4), -. |
| Chicago | Balighi K, Ansari MS, Hashemi Urimi B, Ghanadan A, Tootoonchi N. "Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19." Dermatologic Therapy 35, no. 4 (2022): -. |
| Harvard | Balighi K et al. (2022) 'Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19', Dermatologic Therapy, 35(4), pp. -. |
| Vancouver | Balighi K, Ansari MS, Hashemi Urimi B, Ghanadan A, Tootoonchi N. Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19. Dermatologic Therapy. 2022;35(4):-. |
| BibTex | @article{ author = {Balighi K and Ansari MS and Hashemi Urimi B and Ghanadan A and Tootoonchi N}, title = {Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19}, journal = {Dermatologic Therapy}, volume = {35}, number = {4}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Balighi K AU - Ansari MS AU - Hashemi Urimi B AU - Ghanadan A AU - Tootoonchi N TI - Dramatic Resolution of Cutaneous Lymphoid Hyperplasia After Receiving Intravenous Immunoglobulin for Covid-19 JO - Dermatologic Therapy VL - 35 IS - 4 SP - EP - PY - 2022 ER - |